Antioxidants are among the most popular health-protecting products, sold worldwide without prescription. Indeed, there are many reports showing the benefits of antioxidants but only a few questioning the possible harmful effects of these “drugs”. The normal balance between antioxidants and free radicals in the body is offset when either of these forces prevails. The available evidence on the harmful effects of antioxidants is analyzed in this review. In summary, a hypothesis is presented that “antioxidant-induced stress” results when antioxidants overwhelm the body’s free radicals.
References
[1]
McCord, J.M.; Keele, B.B., Jr; Fridovich, I. An enzyme-based theory of obligate anaerobiosis: The physiological function of superoxide dismutase. Proc. Natl. Acad. Sci. USA 1971, 68, 1024–1027.
[2]
Laranjinha, J. Oxidative Stress: From 1980’s to Recent Update. In Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome; Soares, R., Costa, C., Eds.; Springer, Science + business Media: New York, NY, USA, 2009; pp. 21–32.
[3]
Gutierrez, J.; Ballinger, S.W.; Darley-Usmar, V.M.; Landar, A. Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circ. Res 2006, 99, 924–932.
[4]
Durackova, Z. Some current insights into oxidative stress. Physiol. Res 2010, 59, 459–469.
[5]
Halliwell, B. The wanderings of a free radical. Free Radic. Biol. Med 2009, 46, 531–542.
[6]
Davies, M.J.; Fu, S.; Dean, R.T. Protein hydroperoxides can give rise to reactive free radicals. Biochem. J 1995, 305, 643–649.
[7]
Narwaley, M.; Michail, K.; Arvadia, P.; Siraki, A.G. Drug-induced protein free radical formation is attenuated by unsaturated fatty acids by scavenging drug-derived phenyl radical metabolites. Chem. Res. Toxicol 2011, 24, 1031–1039.
[8]
Rahmanto, A.S.; Morgan, P.E.; Hawkins, C.L.; Davies, M.J. Cellular effects of peptide and protein hydroperoxides. Free Radic. Biol. Med 2010, 48, 1071–1078.
[9]
Yamada, K.; Yamamiya, I.; Utsumi, H. In vivo detection of free radicals induced by diethylnitrosamine in rat liver tissue. Free Radic. Biol. Med 2006, 40, 2040–2046.
[10]
North, J.A.; Spector, A.A.; Buettner, G.R. Detection of lipid radicals by electron paramagnetic resonance spin trapping using intact cells enriched with polyunsaturated fatty acid. J. Biol. Chem 1992, 267, 5743–5746.
[11]
Leonarduzzi, G.; Gamba, P.; Gargiulo, S.; Biasi, F.; Poli, G. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic. Biol. Med 2011, 52, 19–34.
[12]
Halliwell, B.; Gutteridge, J.M. The definition and measurement of antioxidants in biological systems. Free Radic. Biol. Med 1995, 18, 125–126.
[13]
Dündar, Y.; Aslan, R. Antioxidative stress. Eastern J. Med 2000, 5, 45–47.
[14]
Pechanova, O.; Simko, F. Chronic antioxidant therapy fails to ameliorate hypertension: Potential mechanisms behind. J. Hypertens Suppl 2009, 27, S32–S36.
[15]
Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol 2007, 39, 44–84.
[16]
Nemoto, M.; Nishimura, R.; Sasaki, T.; Hiki, Y.; Miyashita, Y.; Nishioka, M.; Fujimoto, K.; Sakuma, T.; Ohashi, T.; Fukuda, K.; et al. Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: A case control study with multi-slice computed tomography. Cardiovasc. Diabetol 2007, 6, 23:1–23:7.
[17]
Voetsch, B.; Jin, R.C.; Bierl, C.; Benke, K.S.; Kenet, G.; Simioni, P.; Ottaviano, F.; Damasceno, B.P.; Annichino-Bizacchi, J.M.; Handy, D.E.; et al. Promoter polymorphisms in the plasma glutathione peroxidase (gpx-3) gene: A novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007, 38, 41–49.
[18]
Naganuma, T.; Nakayama, T.; Sato, N.; Fu, Z.; Soma, M.; Aoi, N.; Hinohara, S.; Doba, N.; Usami, R. Association of extracellular superoxide dismutase gene with cerebral infarction in women: A haplotype-based case-control study. Hereditas 2008, 145, 283–292.
[19]
Samoila, O.C.; Carter, A.M.; Futers, S.T.; Otiman, G.; Anghel, A.; Tamas, L.; Seclaman, E. Polymorphic variants of extracellular superoxide dismutase gene in a romanian population with atheroma. Biochem. Genet 2008, 46, 634–643.
[20]
Manfredi, S.; Federici, C.; Picano, E.; Botto, N.; Rizza, A.; Andreassi, M.G. Gstm1, gstt1 and cyp1a1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: A case-only study. Mutat. Res 2007, 621, 106–112.
[21]
Afanas’ev, I.B. Free radical mechanisms of aging processes under physiological conditions. Biogerontology 2005, 6, 283–290.
Liaudet, L.; Vassalli, G.; Pacher, P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci 2009, 14, 4809–4814.
[24]
Cadenas, E. Mitochondrial free radical production and cell signaling. Mol. Aspects Med 2004, 25, 17–26.
[25]
Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev 2002, 82, 47–95.
[26]
Gu, G.J.; Li, Y.P.; Peng, Z.Y.; Xu, J.J.; Kang, Z.M.; Xu, W.G.; Tao, H.Y.; Ostrowski, R.P.; Zhang, J.H.; Sun, X.J. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J. Appl. Physiol 2008, 104, 1185–1191.
[27]
Glantz, L.; Avramovich, A.; Trembovler, V.; Gurvitz, V.; Kohen, R.; Eidelman, L.A.; Shohami, E. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp. Neurol 2005, 192, 117–124.
[28]
Obrenovitch, T.P. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol. Rev 2008, 88, 211–247.
Vartanian, K.B.; Stevens, S.L.; Marsh, B.J.; Williams-Karnesky, R.; Lessov, N.S.; Stenzel-Poore, M.P. Lps preconditioning redirects tlr signaling following stroke: Trif-irf3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflamm 2011, 8, 140:1–140:12.
[31]
Kaur, R.; Jaggi, A.S.; Singh, N. Studies on effect of stress preconditioning in restrain stress-induced behavioral alterations. Yakugaku Zasshi 2010, 130, 215–221.
Boveris, A.; Navarro, A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free Radic. Biol. Med 2008, 44, 224–229.
[34]
Gomez-Cabrera, M.C.; Domenech, E.; Vina, J. Moderate exercise is an antioxidant: Upregulation of antioxidant genes by training. Free Radic. Biol. Med 2008, 44, 126–131.
[35]
Syu, G.D.; Chen, H.I.; Jen, C.J. Severe exercise and exercise training exert opposite effects on human neutrophil apoptosis via altering the redox status. PLoS One 2011, 6, e24385.
[36]
Fisher-Wellman, K.; Bell, H.K.; Bloomer, R.J. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid. Med. Cell. Longev 2009, 2, 43–51.
[37]
Lima-Cabello, E.; Cuevas, M.J.; Garatachea, N.; Baldini, M.; Almar, M.; Gonzalez-Gallego, J. Eccentric exercise induces nitric oxide synthase expression through nuclear factor-kappab modulation in rat skeletal muscle. J. Appl. Physiol 2010, 108, 575–583.
[38]
George, L.; Lokhandwala, M.F.; Asghar, M. Exercise activates redox-sensitive transcription factors and restores renal d1 receptor function in old rats. Am. J. Physiol. Renal Physiol 2009, 297, F1174–F1180.
[39]
Ji, L.L. Modulation of skeletal muscle antioxidant defense by exercise: Role of redox signaling. Free Radic. Biol. Med 2008, 44, 142–152.
Childs, A.; Jacobs, C.; Kaminski, T.; Halliwell, B.; Leeuwenburgh, C. Supplementation with vitamin c and n-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic. Biol. Med 2001, 31, 745–753.
[42]
Ristow, M.; Zarse, K.; Oberbach, A.; Kloting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.R.; Bluher, M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 8665–8670.
[43]
Peternelj, T.T.; Coombes, J.S. Antioxidant supplementation during exercise training: Beneficial or detrimental? Sports Med 2011, 41, 1043–1069.
[44]
Sevanian, A.; Davies, K.J.; Hochstein, P. Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr 1991, 54, 1129S–1134S.
[45]
Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod 2000, 63, 1035–1042.
[46]
Martin, H.D.; Ruck, C.; Schmidt, M.; Sell, S.; Beutner, S.; Mayer, B.; Walsh, R. Chemistry of carotenoid oxidation and free radical reactions. Pure Appl. Chem 1999, 71, 2253–2262.
[47]
Halliwell, B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys 2008, 476, 107–112.
[48]
Damiani, E.; Astolfi, P.; Carloni, P.; Stipa, P.; Greci, L. Antioxidants: How They Work. In Oxidants in Biology; Valacchi, G., Davis, P.A., Eds.; Springer Science + Buisness Media: New York, NY, USA, 2008; pp. 251–266.
[49]
Botti, H.; Batthyany, C.; Trostchansky, A.; Radi, R.; Freeman, B.A.; Rubbo, H. Peroxynitrite-mediated alpha-tocopherol oxidation in low-density lipoprotein: A mechanistic approach. Free Radic. Biol. Med 2004, 36, 152–162.
[50]
Maguire, J.J.; Wilson, D.S.; Packer, L. Mitochondrial electron transport-linked tocopheroxyl radical reduction. J. Biol. Chem 1989, 264, 21462–21465.
[51]
Duracková, Z. Oxidants, Antioxidants and Oxidative Stress. In Mitochondrial Medicine; Gvozdjáková, A., Ed.; Springer Science + Business Media: New York, NY, USA, 2008; pp. 19–54.
[52]
Liu, C.; Russell, R.M.; Wang, X.D. Alpha-tocopherol and ascorbic acid decrease the production of beta-apo-carotenals and increase the formation of retinoids from beta-carotene in the lung tissues of cigarette smoke-exposed ferrets in vitro. J. Nutr 2004, 134, 426–430.
[53]
Yeum, K.J.; Aldini, G.; Russell, R.M.; Krinsky, N.I. Antioxidant/pro-oxidant Actions of Carotenoids. In Carotenoids; Birkh？user Verlag: Basel, Switzerland, 2009; Volume 5, pp. 235–268.
[54]
Moini, H.; Packer, L.; Saris, N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol. Appl. Pharmacol 2002, 182, 84–90.
[55]
Poljsak, B.; Gazdag, Z.; Jenko-Brinovec, S.; Fujs, S.; Pesti, M.; Belagyi, J.; Plesnicar, S.; Raspor, P. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(vi)-induced damage: An in vivo and in vitro approach. J. Appl. Toxicol 2005, 25, 535–548.
[56]
Maurya, D.K.; Devasagayam, T.P. Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem. Toxicol 2010, 48, 3369–3373.
[57]
Lakshman, M.R. Alpha and omega of carotenoid cleavage. J. Nutr 2004, 134, 241S–245S.
[58]
Polyakov, N.E.; Leshina, T.V.; Konovalova, T.A.; Kispert, L.D. Carotenoids as scavengers of free radicals in a fenton reaction: Antioxidants or pro-oxidants? Free Radic. Biol. Med 2001, 31, 398–404.
[59]
Siems, W.; Wiswedel, I.; Salerno, C.; Crifo, C.; Augustin, W.; Schild, L.; Langhans, C.D.; Sommerburg, O. Beta-carotene breakdown products may impair mitochondrial functions--potential side effects of high-dose beta-carotene supplementation. J. Nutr. Biochem 2005, 16, 385–397.
[60]
Siems, W.; Salerno, C.; Crifo, C.; Sommerburg, O.; Wiswedel, I. Beta-carotene degradation products - formation, toxicity and prevention of toxicity. Forum Nutr 2009, 61, 75–86.
[61]
Long, L.H.; Hoi, A.; Halliwell, B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch. Biochem. Biophys 2010, 501, 162–169.
[62]
Halliwell, B. Biochemistry of oxidative stress. Biochem. Soc. Trans 2007, 35, 1147–1150.
[63]
Halliwell, B.; Lee, C.Y. Using isoprostanes as biomarkers of oxidative stress: Some rarely considered issues. Antioxid. Redox Signal 2010, 13, 145–156.
[64]
Gutteridge, J.M.; Halliwell, B. Antioxidants: Molecules, medicines, and myths. Biochem. Biophys. Res Commun 2010, 393, 561–564.
[65]
Fortes, C.; Virgili, F. Antioxidant vitamins are not “Just antioxidants”: Not necessarily harmful when targeted to the right population. Biofactors 2008, 33, 177–180.
[66]
Ristow, M.; Schmeisser, S. Extending life span by increasing oxidative stress. Free Radic. Biol. Med 2011, 51, 327–336.
[67]
Bowman, T.S.; Bassuk, S.S.; Gaziano, M. Interventional Trials of Antioxidants. In Atherosclerosis and Oxidant Stress: A New Perspective; Hotzman, J.L., Ed.; Springer: New York, NY, USA, 2007; pp. 25–50.
[68]
Stampfer, M.J.; Hennekens, C.H.; Manson, J.E.; Colditz, G.A.; Rosner, B.; Willett, W.C. Vitamin e consumption and the risk of coronary disease in women. N. Engl. J. Med 1993, 328, 1444–1449.
[69]
Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Giovannucci, E.; Colditz, G.A.; Willett, W.C. Vitamin e consumption and the risk of coronary heart disease in men. N. Engl. J. Med 1993, 328, 1450–1456.
[70]
Losonczy, K.G.; Harris, T.B.; Havlik, R.J. Vitamin e and vitamin c supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly. Am. J. Clin. Nutr 1996, 64, 190–196.
[71]
Hasnain, B.I.; Mooradian, A.D. Recent trials of antioxidant therapy: What should we be telling our patients? Cleve. Clin. J. Med 2004, 71, 327–334.
[72]
Todd, S.; Woodward, M.; Tunstall-Pedoe, H.; Bolton-Smith, C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: Results from the scottish heart health study. Am. J. Epidemiol 1999, 150, 1073–1080.
[73]
Myung, S.K.; Ju, W.; Kim, S.C.; Kim, H. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: A meta-analysis. BJOG: Int. J. Obstet. Gynaecol 2011, 118, 1285–1291.
[74]
Stolzenberg-Solomon, R.Z.; Sheffler-Collins, S.; Weinstein, S.; Garabrant, D.H.; Mannisto, S.; Taylor, P.; Virtamo, J.; Albanes, D. Vitamin e intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am. J. Clin. Nutr 2009, 89, 584–591.
[75]
Weinstein, S.J.; Wright, M.E.; Lawson, K.A.; Snyder, K.; Mannisto, S.; Taylor, P.R.; Virtamo, J.; Albanes, D. Serum and dietary vitamin e in relation to prostate cancer risk. Cancer Epidemiol. Biomark. Prev 2007, 16, 1253–1259.
[76]
Bobe, G.; Weinstein, S.J.; Albanes, D.; Hirvonen, T.; Ashby, J.; Taylor, P.R.; Virtamo, J.; Stolzenberg-Solomon, R.Z. Flavonoid intake and risk of pancreatic cancer in male smokers (finland). Cancer Epidemiol. Biomark. Prev 2008, 17, 553–562.
[77]
Heart Protection Study Collaborative Group. Mrc/bhf heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002, 360, 23–33.
[78]
Klipstein-Grobusch, K.; Geleijnse, J.M.; den Breeijen, J.H.; Boeing, H.; Hofman, A.; Grobbee, D.E.; Witteman, J.C. Dietary antioxidants and risk of myocardial infarction in the elderly: The rotterdam study. Am. J. Clin. Nutr 1999, 69, 261–266.
[79]
Yusuf, S.; Dagenais, G.; Pogue, J.; Bosch, J.; Sleight, P. Vitamin e supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med 2000, 342, 154–160.
[80]
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: Results of the gissi-prevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell’infarto miocardico. Lancet 1999, 354, 447–455.
[81]
Rytter, E.; Vessby, B.; Asgard, R.; Ersson, C.; Moussavian, S.; Sjodin, A.; Abramsson-Zetterberg, L.; Moller, L.; Basu, S. Supplementation with a combination of antioxidants does not affect glycaemic control, oxidative stress or inflammation in type 2 diabetes subjects. Free Radic. Res 2010, 44, 1445–1453.
[82]
Suksomboon, N.; Poolsup, N.; Sinprasert, S. Effects of vitamin e supplementation on glycaemic control in type 2 diabetes: Systematic review of randomized controlled trials. J. Clin. Pharm. Ther 2011, 36, 53–63.
[83]
Arain, M.A.; Abdul Qadeer, A. Systematic review on “Vitamin e and prevention of colorectal cancer”. Pak. J. Pharm. Sci 2010, 23, 125–130.
[84]
Ward, N.C.; Hodgson, J.M.; Croft, K.D.; Burke, V.; Beilin, L.J.; Puddey, I.B. The combination of vitamin c and grape-seed polyphenols increases blood pressure: A randomized, double-blind, placebo-controlled trial. J. Hypertens 2005, 23, 427–434.
[85]
Cheung, M.C.; Zhao, X.Q.; Chait, A.; Albers, J.J.; Brown, B.G. Antioxidant supplements block the response of hdl to simvastatin-niacin therapy in patients with coronary artery disease and low hdl. Arterioscler. Thromb. Vasc. Biol 2001, 21, 1320–1326.
[86]
Kim, Y.I. Does a high folate intake increase the risk of breast cancer? Nutr. Rev 2006, 64, 468–475.
[87]
Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L., Jr; Valanis, B.; Williams, J.H., Jr; et al. Risk factors for lung cancer and for intervention effects in caret, the beta-carotene and retinol efficacy trial. J. Natl. Cancer Inst. 1996, 88, 1550–1559.
[88]
Albanes, D.; Heinonen, O.P.; Taylor, P.R.; Virtamo, J.; Edwards, B.K.; Rautalahti, M.; Hartman, A.M.; Palmgren, J.; Freedman, L.S.; Haapakoski, J.; et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance. J. Natl. Cancer Inst 1996, 88, 1560–1570.
[89]
The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin e and beta carotene on the incidence of lung cancer and other cancers in male smokers. The alpha-tocopherol, beta carotene cancer prevention study group. N. Engl. J. Med. 1994, 330, 1029–1035.
[90]
Bjelakovic, G.; Nikolova, D.; Simonetti, R.G.; Gluud, C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 2004, 364, 1219–1228.
[91]
Myung, S.K.; Kim, Y.; Ju, W.; Choi, H.J.; Bae, W.K. Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trials. Ann. Oncol 2010, 21, 166–179.
[92]
Mursu, J.; Robien, K.; Harnack, L.J.; Park, K.; Jacobs, D.R., Jr. Dietary supplements and mortality rate in older women: The iowa women’s health study. Arch. Intern. Med. 2011, 171, 1625–1633.
